INLYTA

Inlyta is classified as a targeted therapy, not a chemotherapy medication. It functions by selectively targeting receptor tyrosine kinases (RTKs) found on certain cells’ surfaces, rather than indiscriminately destroying rapidly dividing cells like conventional chemotherapy drugs.

The study results indicated that a higher percentage of patients who were treated with the combination of Keytruda and Inlyta (86%) experienced longer survival compared to those who received sunitinib alone (77%). Furthermore, at the 15-month mark, half of the patients who received Keytruda and Inlyta were still living without any progression, growth, or worsening of their cancer.

In a study of Western patients with cytokine-refractory mRCC, the objective response rate (ORR) was 44.2% (95% CI 30.5, 58.7). The median time to progression was 15.7 months (95% CI 8.4, 23.4) and the median overall survival (OS) was 29.9 months (95% CI 20.3, not estimable).

This medication is a brand name drug, but there may be a generic version available. The average cost for a 30-day supply of 1MG tablets is $6,349.66. However, you can purchase Inlyta at a discounted price of $3,600.44 by using the NowPatient Rx Advantage Card, which will save you 43%. We advise you to compare prices even if this drug is covered by Medicare or your insurance.

Imatinib may also lead to hair loss, with 6.6% of patients reporting this side effect, although complete hair loss is rare. In a study comparing axitinib and sorafenib for metastatic renal cancer, 4% of patients treated with axitinib experienced alopecia.

Doxorubicin is highly effective against various types of cancers due to its ability to eliminate cancer cells at any stage of their development.

There is currently no generic version of Inlyta available in the United States. It is important to be cautious of fraudulent online pharmacies that may sell illegal and potentially unsafe counterfeit versions of Inlyta.

While taking axitinib and for 2 weeks after the last dose, it is important to avoid breastfeeding. If you become pregnant, please inform your care provider. Hugging and kissing are safe. However, when it comes to sexual activity while on oral chemotherapy, it is recommended to take special precautions. Feel free to ask your care provider for guidance.

Medicare prescription drug plans often place Inlyta on Tier 5 of their formulary, which typically means higher out-of-pocket costs for the medication. Most plans have 5 tiers, so it’s important to check if your plan has any restrictions on coverage for Inlyta.

Inlyta, containing the active ingredient axitinib, is a medication available in tablet form (1, 3, 5, and 7 mg) and is used to treat advanced renal cell carcinoma in adults, a form of kidney cancer.

Inlyta is approved for treating advanced renal cell carcinoma (RCC) in adults who have not responded to previous treatment with sunitinib or a cytokine. A qualified physician should administer Inlyta, and the recommended dosage is 5 mg taken twice daily.

Immunotherapy is a form of treatment that harnesses the power of the body’s immune system to fight against diseases. Immuno-oncology, on the other hand, focuses specifically on using immunotherapy to target and treat cancer.

Immunotherapy instructs healthy cells to identify cancer cells and prevent their proliferation. Unlike chemotherapy, which directly destroys cancerous cells and tumors, immunotherapy stimulates the immune system to function more efficiently and effectively in combating cancer independently.

Axitinib, also known as Inlyta and pronounced ak-sih-tih-nib, is a targeted cancer medication used to treat advanced kidney cancer that has spread.

You may experience nausea, vomiting, loss of appetite, dizziness, tiredness/weakness, weight loss, temporary hair loss, dry skin, cough, headache, altered sense of taste, hoarseness, constipation, or upset stomach. If any of these symptoms persist or worsen, please inform your doctor or pharmacist immediately.

The median overall survival was 20.1 months (95% CI 16.7-23.4) for patients treated with axitinib and 19.2 months (17.5-22.3) for those treated with sorafenib. The hazard ratio (HR) was 0.969 (95% CI 0.800-1.174) with a one-sided p-value of 0.3744.

You have the option to take this medicine with or without food. Make sure to take each dose at least 12 hours apart. Take the tablet whole with a glass of water.

Cancer cachexia, a condition characterized by weight loss, is triggered by an elevated caloric requirement in the body. This can be attributed to either cancer itself or the treatment of cancer. Individuals experiencing cachexia undergo a depletion of both muscle and fat, resulting in weakness, fatigue, and a diminished ability to perform their regular activities.

Inlyta (axitinib) is a medication that inhibits kinases and is used to treat advanced renal cell carcinoma in patients who have not responded to previous systemic therapy for this type of cancer.

The primary concerns that arise frequently are diarrhea and other indications of colitis, characterized by inflammation in the large intestine. These symptoms may encompass stomach cramps and the presence of blood or mucus in the stool. Certain individuals may also experience nausea and vomiting. All of these factors can contribute to weight loss and fatigue.

To take INLYTA, swallow the tablets whole with a glass of water. You have the option to take it with or without food. However, it is important to avoid consuming grapefruit juice or grapefruit while on INLYTA, as they can alter the levels of the medication in your body.

Although Metronidazole is generally considered safe, it is crucial to be mindful of potential interactions with other substances, including food. Bananas, in particular, have been known to interact with specific medications due to their elevated potassium levels.

Please follow your doctor’s instructions and continue taking INLYTA for as long as prescribed. While this medication helps manage your condition, it does not provide a cure. It’s crucial to keep taking your medication even if you are feeling better.

Consider avoiding certain fruits based on your symptoms. For instance, citrus fruits can exacerbate mouth sores and worsen dry mouth. Additionally, whole fruits such as apples, apricots, and pears may be difficult for some cancer patients to eat due to mouth sores, difficulty swallowing, dry mouth, or nausea.

While there are no known drug interactions between Inlyta and alcohol, it is advisable to limit alcohol consumption while taking Inlyta. This precaution is due to the potential liver damage that Inlyta may cause.

Increase your intake of potassium- and magnesium-rich foods such as bananas, potatoes, orange juice, tomatoes, and apricots when you are feeling better.

INLYTA can lead to significant side effects, such as high blood pressure (hypertension). This condition is frequently observed with the use of INLYTA and can occasionally be severe. It is important for your healthcare provider to monitor your blood pressure regularly while you are undergoing treatment with INLYTA.

To prevent hyperkalemia, it is recommended to avoid taking potassium supplements or consuming potassium-rich foods such as bananas, spinach, and potatoes while taking spironolactone.

The most frequently reported (20%) side effects after using INLYTA included diarrhea, high blood pressure, fatigue, loss of appetite, nausea, hoarseness, hand-foot syndrome, weight loss, vomiting, weakness, and constipation.

Avocado is commonly used as a nutritional supplement during cancer chemotherapy to alleviate symptoms such as dry mouth, constipation, and mouth sores. One way to incorporate avocados into your diet is by pureeing them and spreading them on toast. Alternatively, you can slice them and use them as a topping for cereals, beans, or soups.

Avoid consuming lightly cooked or raw fish, such as sushi. Refrain from consuming soft-cooked eggs or foods that contain raw eggs, such as homemade mayonnaise. Do not consume unpasteurized cheeses and dairy products. Ensure that fruits and vegetables are thoroughly washed before consumption.

According to Nouhavandi, it is recommended to avoid consuming dairy products such as yogurt or ice cream at least two hours before and six hours after taking antibiotics like ciprofloxacin (Cipro), levofloxacin (Levaquin), moxifloxacin (Avelox), and certain tetracyclines.